Consensus Waters Corporation Boerse Muenchen

Stocks

WAZ

US9418481035

Advanced Medical Equipment & Technology

Real-time Boerse Muenchen 06:43:05 28/08/26 am AEST			5-day change	1st Jan Change
362.40 ^EUR	+2.08%		-0.67%	+8.96%

28/08	Waters Shares Rise After Piper Sandler Upgrade	MT
27/08	Piper Sandler Upgrades Waters to Overweight From Neutral, $480 Price Target	MT

Evolution of the Average Target: Waters Corporation

Evolution of the Target Price: Waters Corporation

Changes in Analyst Recommendations: Waters Corporation

2704465583.icySpl0VoEzYwAmlH7-38gqGeRT6f0tK78e-0DGiXgI.w5igwTAllSK_hk7Ra-7QhEHhF0SJChwopYX85W79GWnlr_SVP2_uD56VOQ~7c38fcb745e177850a50bc2a57750225

Analysts' recommendations: Waters Corporation

28/08	Waters Shares Rise After Piper Sandler Upgrade	MT
27/08	Piper Sandler Upgrades Waters to Overweight From Neutral, $480 Price Target	MT
27/08	Analyst recommendations: Block, Celsius, Crowdstrike, Gitlab, Nvidia…
25/08	Waters' Q4 Guide Conservative, 2027 Growth Could Reach High Single Digits, RBC Says	MT
06/08	Goldman Sachs Adjusts Waters Price Target to $465 From $425	MT
06/08	JPMorgan Adjusts Waters Price Target to $400 From $370	MT
06/08	Wells Fargo Adjusts Waters Price Target to $400 From $370	MT
06/08	Stifel Nicolaus Adjusts Waters Price Target to $420 From $380	MT
05/08	RBC Capital Adjusts Waters Price Target to $475 From $435, Maintains Outperform Rating	MT
05/08	Deutsche Bank Adjusts Waters Price Target to $400 From $380, Maintains Hold Rating	MT
05/08	Barclays Adjusts Price Target on Waters to $460 From $425, Maintains Overweight Rating	MT
05/08	Evercore ISI Adjusts Price Target on Waters to $420 From $410, Maintains Outperform Rating	MT
05/08	Leerink Partners Adjusts Price Target on Waters to $450 From $420, Maintains Outperform Rating	MT
05/08	Bernstein Adjusts Price Target on Waters to $450 From $435, Maintains Outperform Rating	MT
05/08	Jefferies Adjusts Price Target on Waters to $455 From $450, Maintains Buy Rating	MT
05/08	TD Cowen Upgrades Waters to Buy From Hold, Adjusts Price Target to $475 From $408	MT
16/07	TD Cowen Adjusts Price Target on Waters to $408 From $385, Keeps Hold Rating	MT
14/07	Goldman Sachs Adjusts Price Target on Waters to $425 From $380, Maintains Buy Rating	MT
14/07	Baird Adjusts Price Target on Waters to $418 From $387, Maintains Outperform Rating	MT
10/07	Morgan Stanley Adjusts Price Target on Waters to $390 From $350	MT
09/07	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
09/07	RBC Capital Initiates Waters at Outperform With $435 Price Target	MT
06/07	Evercore ISI Adjusts Price Target on Waters to $410 From $380	MT
11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
03/06	HSBC Adjusts Price Target on Waters to $435 From $415, Maintains Buy Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	THERMO FISHER SCIENTIFIC, INC.					-0.36%
	DANAHER CORPORATION					+5.85%
	INTUITIVE SURGICAL, INC.					+29.05%
	BOSTON SCIENTIFIC CORPORATION					+30.14%
	EDWARDS LIFESCIENCES CORPORATION					+11.22%
	SIEMENS HEALTHINEERS AG					+14.86%
	AGILENT TECHNOLOGIES, INC.					+3.72%
	WATERS CORPORATION					+5.27%
	RESMED, INC.					+4.16%
	Average					+11.55%
	Weighted average by Cap.					+10.53%